Inicio › Cáncer metastásico › Minnesota › Rochester
Ensayos clínicos de Cáncer metastásico en Rochester, MN
31 estudios para Cáncer metastásico buscan participantes en centros de Rochester y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- Mayo Clinic in Rochester, Rochester
Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
Reclutando
- Mayo Clinic in Rochester, Rochester
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
ReclutandoFase 2
- Mayo Clinic in Rochester, Rochester
PRE-ISPY Phase I/II Oncology Platform Program
ReclutandoFase 1/2
- Mayo Clinic Comprehensive Cancer Center, Rochester
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
ReclutandoFase 2/3
- Mayo Clinic, Rochester
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 3
- Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
- Mayo Clinic Pharmacy, Rochester
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- y 3 más
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
ReclutandoFase 1
- Mayo Clinic Rochester, Rochester
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
ReclutandoFase 2
- Mayo Clinic Cancer Center, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
ReclutandoFase 2/3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ReclutandoFase 3
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutandoFase 3
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
ReclutandoFase 2
- Mayo Clinic Rochester, Rochester
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
ReclutandoFase 1/2
- Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
CREO - Microwave Ablation Feasibility Study
Reclutando
- Mayo Clinic Rochester, Rochester
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
ReclutandoFase 1
- Mayo Clinic in Rochester, Rochester
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
ReclutandoFase 3
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
ReclutandoFase 1
- Mayo Clinic - Rochester, Rochester
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
ReclutandoFase 2
- Research Site, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Mayo Clinic, Rochester
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
ReclutandoFase 1/2
- Crinetics Study Site, Rochester
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Mayo Clinic (Minnesota), Rochester
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
ReclutandoFase 1
- Mayo Clinic, Rochester
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
ReclutandoEstudio observacional
- Mayo Clinic in Rochester, Rochester
Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients
Reclutando
- Mayo Clinic in Rochester, Rochester
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
ReclutandoEstudio observacional
- Mayo Clinic in Rochester, Rochester
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
ReclutandoFase 2/3
- Mayo Clinic Comprehensive Cancer Center, Rochester
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
ReclutandoFase 2/3
- Mayo Clinic Rochester, Rochester
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
ReclutandoEstudio observacional
- Mayo Clinic in Rochester, Rochester
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
ReclutandoFase 3
- Mayo Clinic - Rochester, Mn, Rochester
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
ReclutandoFase 1/2
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
ReclutandoFase 1/2
- Mayo Clinic in Minnesota, Rochester
Ensayos de Cáncer metastásico en otras ciudades
- Houston, TX104 estudios
- New York City, NY93 estudios
- Nashville, TN70 estudios
- Boston, MA63 estudios
- Los Angeles, CA57 estudios
- St. Louis, MO54 estudios
- Arlington, VA53 estudios
- Philadelphia, PA46 estudios
- Chicago, IL45 estudios
- San Antonio, TX44 estudios
- Washington, DC43 estudios
- Dallas, TX42 estudios
Otros estudios en Rochester
- Cáncer de seno42 estudios
- Cáncer de pulmón de células no pequeñas37 estudios
- Cáncer (todos los tipos)30 estudios
- Cáncer de ovario29 estudios
- Cáncer del colon y del recto29 estudios
- Mieloma múltiple24 estudios
- Fallo cardíaco22 estudios
- Cáncer de próstata22 estudios
- Cáncer de páncreas22 estudios
- Cáncer de endometrio20 estudios
- Cáncer de pulmón20 estudios
- Leucemia linfocítica crónica18 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.